相似文献
1
Selective estrogen receptor modulators: tissue actions and potential for CNS protection.
CNS Drug Rev. 2002 Fall;8(3):309-30. doi: 10.1111/j.1527-3458.2002.tb00230.x.
2
Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
Proc Soc Exp Biol Med. 1998 Jan;217(1):45-52. doi: 10.3181/00379727-217-44204.
3
Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.
Cancer Invest. 2001;19(6):649-59. doi: 10.1081/cnv-100104293.
4
Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues.
J Ethnopharmacol. 2021 Jul 15;275:114096. doi: 10.1016/j.jep.2021.114096. Epub 2021 Apr 3.
5
Progress in the prevention of breast cancer: concept to reality.
J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):269-77. doi: 10.1016/s0960-0760(00)00103-5.
6
Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene.
ChemMedChem. 2007 Oct;2(10):1520-6. doi: 10.1002/cmdc.200700104.
7
[Specific estrogen receptor modulators (SERMs)].
Presse Med. 2002 Sep 7;31(28):1323-8.
8
Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
Bone. 1996 Jun;18(6):621-7. doi: 10.1016/8756-3282(96)00085-3.
9
Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques.
Psychoneuroendocrinology. 2002 May;27(4):431-45. doi: 10.1016/s0306-4530(01)00054-3.
10
Tamoxifen to raloxifene and beyond.
Semin Oncol. 2001 Jun;28(3):260-73. doi: 10.1053/sonc.2001.23492.
引用本文的文献
1
Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression.
Front Pharmacol. 2025 Feb 20;16:1528544. doi: 10.3389/fphar.2025.1528544. eCollection 2025.
2
Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System-A Review.
Biomedicines. 2024 Jan 15;12(1):184. doi: 10.3390/biomedicines12010184.
3
Effects of estrogen and raloxifene on synaptic density in the hippocampal CA1 region of ovariectomized rats.
Clinics (Sao Paulo). 2023 Nov 27;78:100312. doi: 10.1016/j.clinsp.2023.100312. eCollection 2023.
4
Folding Mitochondrial-Mediated Cytosolic Proteostasis Into the Mitochondrial Unfolded Protein Response.
Front Cell Dev Biol. 2021 Sep 23;9:715923. doi: 10.3389/fcell.2021.715923. eCollection 2021.
5
Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
Int J Mol Sci. 2020 Oct 14;21(20):7586. doi: 10.3390/ijms21207586.
6
Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology.
Front Neurol. 2020 Feb 14;11:87. doi: 10.3389/fneur.2020.00087. eCollection 2020.
7
Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous system.
Neural Regen Res. 2017 Aug;12(8):1231-1240. doi: 10.4103/1673-5374.213536.
8
Neuroprotective effects of estrogen in CNS injuries: insights from animal models.
Neurosci Neuroecon. 2017;6:15-29. doi: 10.2147/NAN.S105134. Epub 2017 Jul 4.
9
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
Schizophr Bull. 2016 Mar;42(2):309-17. doi: 10.1093/schbul/sbv149. Epub 2015 Nov 20.
10
Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.
Brain Res Bull. 2014 Oct;109:22-31. doi: 10.1016/j.brainresbull.2014.09.004. Epub 2014 Sep 20.
本文引用的文献
1
Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats.
J Bone Miner Res. 2002 Dec;17(12):2256-64. doi: 10.1359/jbmr.2002.17.12.2256.
2
Hormone replacement therapy with estradiol valerate and cyproterone acetate: effects on endothelium-dependent vasodilatation and arterial wall compliance.
Maturitas. 2002 May 20;42(1):45-53. doi: 10.1016/s0378-5122(02)00002-6.
3
Estrogen actions throughout the brain.
Recent Prog Horm Res. 2002;57:357-84. doi: 10.1210/rp.57.1.357.
4
Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.
J Womens Health Gend Based Med. 2002 Apr;11(3):291-301. doi: 10.1089/152460902753668484.
5
Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat.
J Endocrinol. 2002 Mar;172(3):441-8. doi: 10.1677/joe.0.1720441.
6
Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.
JAMA. 2002 Feb 20;287(7):847-57. doi: 10.1001/jama.287.7.847.
7
Selective estrogen receptor modulator effects in the rat brain.
Neuroendocrinology. 2002 Jan;75(1):24-33. doi: 10.1159/000048218.
8
Androgens and estrogens in relation to hot flushes during the menopausal transition.
Maturitas. 2002 Jan 30;41(1):69-77. doi: 10.1016/s0378-5122(01)00256-0.
9
Raloxifene: risks and benefits.
Ann N Y Acad Sci. 2001 Dec;949:295-303. doi: 10.1111/j.1749-6632.2001.tb04036.x.
10
What would be the properties of an ideal SERM?
Ann N Y Acad Sci. 2001 Dec;949:261-78. doi: 10.1111/j.1749-6632.2001.tb04031.x.
Zotero 插件